Investment
Features
FeesSafety
Academy
More
Pluang+

Compare JPMorgan Chase & Co (JPM) vs Oscar Health Inc (OSCR) Price & Performance

JPMorgan Chase & CoTrade
Oscar Health IncTrade

Price performance (Past 24H)

Key statistics

JPMorgan Chase & Co vs Oscar Health Inc — how do they compare? JPMorgan Chase & Co trades at $365.07 (market cap $962.37B), while Oscar Health Inc trades at $28.85 (market cap $8.63B). The key difference: JPMorgan Chase & Co is far larger — about 111.5× Oscar Health Inc's market cap, and JPMorgan Chase & Co pays a 1.66% dividend while Oscar Health Inc pays none. Which is the better fit depends on your goals.

JPMOSCR
Market Cap
$962.37B$8.63B
Volume
10,479,943
Sector
FinancialsHealth
52-Week High
$362.04$32.18
52-Week Low
$282.84$10.85
Dividend Yield
1.66%
Enterprise Value
$4.99B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

JPMorgan Chase & Co

JPMorgan Chase & Co. (JPM) trades at $365.11, up 1.48% in 24 hours, with a bullish technical signal and strong fundamentals including a 33.38% net income margin and 18.43% ROE. Recent earnings beat expectations in Q1 and Q2 2026, while analyst consensus is a Moderate Buy with a $374.18 price target. CEO Jamie Dimon's shareholder letter highlights economic risks, but institutional buying and resilient sector performance support optimism.

The outlook for JPM is positive, driven by earnings momentum and sector strength, though risks include geopolitical tensions and potential economic headwinds noted by management. Upside to the consensus target offers opportunity, but investors should weigh high RSI levels and macroeconomic cautions.

Oscar Health Inc

OSCR trades at $27.97, up 1.08% today, with a bearish technical signal but strong recent earnings beats in Q1 and Q2 2026. The company reported record profitability and raised its full-year outlook, driven by membership growth and cost controls. Key support lies at $26, with resistance at $28. Revenue surged 70% year-over-year in H1 2026 to $4.9 billion, per PYMNTS on August 6, 2026.

Outlook is positive due to robust growth and margin expansion, but risks include execution challenges and competitive pressures. Analysts have a consensus price target of $32.50, with 27% buy ratings. The stock offers value with a P/S of 0.53, though net income volatility remains a concern.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About JPMorgan Chase & Co

JPMorgan Chase & Co. provides global financial services and retail banking. The Company provides services such as investment banking, treasury and securities services, asset management, private banking, card member services, commercial banking, and home finance. JP Morgan Chase serves business enterprises, institutions, and individuals.

Read more on JPM

About Oscar Health Inc

Oscar Health, Inc. is a health insurance company that utilizes a technology-driven approach to simplify the healthcare experience. The company offers individual, small-group, and Medicare Advantage plans, primarily through a platform that integrates technology, data, and design to provide members with a personalized, efficient healthcare journey. Oscar aims to lower costs and improve engagement by focusing on consumer-centricity and modernizing the traditional health insurance model.

Read more on OSCR